Beam Therapeutics Inc. announced that its chief financial officer, Terry-Ann Burrell, will be leaving the company effective August 9, 2024 to pursue a new opportunity as vice chairman of investment banking at JPMorgan Chase. As part of a transition process, the company has initiated a search for a successor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.62 USD | -4.69% |
|
+7.42% | -5.88% |
15/07 | Beam Therapeutics' Finance Chief Terry-Ann Burrell Leaving in August | MT |
15/07 | Beam Therapeutics CFO Terry-Ann Burrell Departing in August | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.88% | 202.17Cr | |
+22.15% | 4.66TCr | |
+45.55% | 4.17TCr | |
-2.37% | 4.12TCr | |
+33.84% | 3.24TCr | |
-6.35% | 2.81TCr | |
+20.42% | 2.82TCr | |
+48.83% | 1.45TCr | |
+45.00% | 1.37TCr | |
+0.06% | 1.22TCr |
- Stock Market
- Equities
- BEAM Stock
- News Beam Therapeutics Inc.
- Beam Therapeutics Inc. Announces Resignation of Terry-Ann Burrell as Chief Financial Officer, Effective August 9, 2024